February 6, 2020 by Jason Wertheimer Endpoints News Jeffrey Bluestone exits Parker and switches focus back to autoimmune diseases in cell therapy 2.0 launch Learn More
February 6, 2020 by Jason Wertheimer San Francisco Business Times Why the CEO of Sean Parker’s cancer institute left to help the ‘cellular police’ arrest diseases like diabetes Learn More